Etanercept for alzheimer disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Feb 2010: Trial registered, NCT01068353
  2. 23 Apr 2014: Trial completed, NCT01068353

The trials

NCT01068353: Safety and Tolerability of Etanercept in Alzheimer's Disease

State
Completed
Phase
Phase 2
People
41 taking part
Started
Jan 2011
Primary completion
Dec 2013
Arms
Etanercept
Results
None posted
  1. 12 Feb 2010: Trial registered
  2. 23 Apr 2014: Trial completed

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.